Myovant Sciences' new campaign brings together men with prostate cancer to share stories of diagnoses, treatment, stigma and the importance of support.
September 26, 2022 02:10 PM EDTUpdated 03:44 PM
Pharma
Marketing

My­ovant launch­es new pa­tient sto­ry­telling plat­form, de­buts with video se­ries on prostate can­cer

Beth Snyder Bulik

Senior Editor

My­ovant Sci­ences’ new video se­ries fea­tures frank con­ver­sa­tions among men who have prostate can­cer — but it’s just the be­gin­ning. The prostate can­cer se­ries is My­ovant …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Bris­tol My­er­s' TYK2 in­hibitor suc­ceeds in pair of Phase 3 pso­ri­at­ic arthri­tis tri­als

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

A service from the Financial Times